Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Ebolavirus VP35 interacts with the cytoplasmic dynein light chain 8.

Kubota T, Matsuoka M, Chang TH, Bray M, Jones S, Tashiro M, Kato A, Ozato K.

J Virol. 2009 Jul;83(13):6952-6. doi: 10.1128/JVI.00480-09. Epub 2009 Apr 29.

2.

Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein.

Reid SP, Cárdenas WB, Basler CF.

Virology. 2005 Oct 25;341(2):179-89. Epub 2005 Aug 10.

3.

The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.

Trunschke M, Conrad D, Enterlein S, Olejnik J, Brauburger K, Mühlberger E.

Virology. 2013 Jul 5;441(2):135-45. doi: 10.1016/j.virol.2013.03.013. Epub 2013 Apr 11.

4.

Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein.

Ramaswamy VK, Di Palma F, Vargiu AV, Corona A, Piano D, Ruggerone P, Zinzula L, Tramontano E.

Virus Res. 2018 Mar 2;247:61-70. doi: 10.1016/j.virusres.2018.02.003. Epub 2018 Feb 7.

PMID:
29427597
5.

The 8-kDa dynein light chain binds to its targets via a conserved (K/R)XTQT motif.

Lo KW, Naisbitt S, Fan JS, Sheng M, Zhang M.

J Biol Chem. 2001 Apr 27;276(17):14059-66. Epub 2001 Jan 8.

6.

Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.

Ilinykh PA, Lubaki NM, Widen SG, Renn LA, Theisen TC, Rabin RL, Wood TG, Bukreyev A.

J Virol. 2015 Aug;89(15):7567-83. doi: 10.1128/JVI.00924-15. Epub 2015 May 13.

7.

Ebola virus VP35 interaction with dynein LC8 regulates viral RNA synthesis.

Luthra P, Jordan DS, Leung DW, Amarasinghe GK, Basler CF.

J Virol. 2015 May;89(9):5148-53. doi: 10.1128/JVI.03652-14. Epub 2015 Mar 4.

8.

Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.

Prins KC, Binning JM, Shabman RS, Leung DW, Amarasinghe GK, Basler CF.

J Virol. 2010 Oct;84(20):10581-91. doi: 10.1128/JVI.00925-10. Epub 2010 Aug 4.

9.

Characterization of the RNA silencing suppression activity of the Ebola virus VP35 protein in plants and mammalian cells.

Zhu Y, Cherukuri NC, Jackel JN, Wu Z, Crary M, Buckley KJ, Bisaro DM, Parris DS.

J Virol. 2012 Mar;86(6):3038-49. doi: 10.1128/JVI.05741-11. Epub 2012 Jan 11.

10.

Serological reactivity of baculovirus-expressed Ebola virus VP35 and nucleoproteins.

Groen J, van den Hoogen BG, Burghoorn-Maas CP, Fooks AR, Burton J, Clegg CJ, Zeller H, Osterhaus AD.

Microbes Infect. 2003 Apr;5(5):379-85.

PMID:
12737993
11.

Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.

Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, Amarasinghe GK, Basler CF.

Cell Host Microbe. 2013 Jul 17;14(1):74-84. doi: 10.1016/j.chom.2013.06.010.

12.

Ebolavirus VP35 is a multifunctional virulence factor.

Leung DW, Prins KC, Basler CF, Amarasinghe GK.

Virulence. 2010 Nov-Dec;1(6):526-31. Epub 2010 Nov 1.

13.

Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain.

Schümann M, Gantke T, Mühlberger E.

J Virol. 2009 Sep;83(17):8993-7. doi: 10.1128/JVI.00523-09. Epub 2009 Jun 10.

14.

A simulation investigation on interaction mechanism between Ebola nucleoprotein and VP35 peptide.

Ding JN, Zhang YJ, Zhong H, Ao CC, Han JG.

J Biomol Struct Dyn. 2018 Mar;36(4):1009-1028. doi: 10.1080/07391102.2017.1307143. Epub 2017 Apr 10.

PMID:
28298161
15.

The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified.

Groseth A, Charton JE, Sauerborn M, Feldmann F, Jones SM, Hoenen T, Feldmann H.

Virus Res. 2009 Mar;140(1-2):8-14. doi: 10.1016/j.virusres.2008.10.017. Epub 2008 Dec 16.

16.

Putative endogenous filovirus VP35-like protein potentially functions as an IFN antagonist but not a polymerase cofactor.

Kondoh T, Manzoor R, Nao N, Maruyama J, Furuyama W, Miyamoto H, Shigeno A, Kuroda M, Matsuno K, Fujikura D, Kajihara M, Yoshida R, Igarashi M, Takada A.

PLoS One. 2017 Oct 17;12(10):e0186450. doi: 10.1371/journal.pone.0186450. eCollection 2017.

17.

Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35 Complex.

Kirchdoerfer RN, Abelson DM, Li S, Wood MR, Saphire EO.

Cell Rep. 2015 Jul 7;12(1):140-149. doi: 10.1016/j.celrep.2015.06.003. Epub 2015 Jun 25.

18.

Ebola virus VP35-VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles.

Johnson RF, McCarthy SE, Godlewski PJ, Harty RN.

J Virol. 2006 Jun;80(11):5135-44.

19.
20.

Development of RNA aptamers targeting Ebola virus VP35.

Binning JM, Wang T, Luthra P, Shabman RS, Borek DM, Liu G, Xu W, Leung DW, Basler CF, Amarasinghe GK.

Biochemistry. 2013 Nov 26;52(47):8406-19. doi: 10.1021/bi400704d. Epub 2013 Nov 14.

Supplemental Content

Support Center